Xencor Inc (XNCR) was one of the Russell 2000's biggest losers for Monday December 28 as the stock slid 6.84% to $13.89, a loss of $-1.02 per share. Starting at an opening price of $14.82 a share, the stock traded between $13.83 and $14.82 over the course of the trading day. Volume was 113,407 shares over 1,118 trades, against an average daily volume of 342,783 shares and a total float of 40.48 million.
The losses send Xencor Inc down to a market cap of $562.23 million. In the last year, Xencor Inc has traded between $24.82 and $10.68, and its 50-day SMA is currently $13.59 and 200-day SMA is $16.65.
Xencor Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
Xencor Inc is based out of Monrovia, CA and has some 39 employees. Its CEO is Bassil I. Dahiyat.
For a complete fundamental analysis analysis of Xencor Inc, check out Equities.com’s Stock Valuation Analysis report for XNCR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.